apigenin and Abdominal-Pain

apigenin has been researched along with Abdominal-Pain* in 2 studies

Other Studies

2 other study(ies) available for apigenin and Abdominal-Pain

Article	Year
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome. Minerva gastroenterology, 2023, Volume: 69, Issue:1 Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders. IBS is characterized by recurrent chronic abdominal pain and altered bowel habits in the absence of organic damage. Although there are reviews and guidelines for treating IBS, the complexity and diversity of IBS presentation make treatment difficult. Treatment of IBS focuses on relieving symptoms as mild signs and symptoms can often be controlled by managing stress and by making changes in diet and lifestyle. The use of nutraceutical compounds has been advocated as a possible alternative treatment in patients with IBS. COLONIR. An initial cohort of 1004 consecutive patients referred to 25 different Units of Internal Medicine a/o Gastroenterology in Italy to perform colonoscopy for intestinal symptoms was asked to participate. Patients were treated for 2 months with three doses of nutraceuticals/day after meals namely COLONIR. After 2 months, 899 patients completed the follow-up. COLONIR. These promising results, here reported, need to be confirmed, valuating the efficacy of COLONIR Topics: Abdominal Pain; Chamomile; Charcoal; Chronic Pain; Dietary Supplements; Flower Essences; Gastrointestinal Diseases; Glycyrrhiza; Humans; Irritable Bowel Syndrome; Mentha; Probiotics; Tryptophan	2023
Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin. Nutrients, 2019, Dec-20, Volume: 12, Issue:1 Abdominal pain is a frequent symptom of irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBDs). Although the knowledge of these pathologies is progressing, new therapeutic strategies continue to be investigated. In the present study, the effect of a system of molecules of natural origin (a medical device according to EU Directive 93/42/EC, engineered starting from Topics: Abdominal Pain; Aloe; Animals; Chamomile; Colitis; Disease Models, Animal; Flavonoids; Male; Plant Preparations; Rats; Rats, Sprague-Dawley; Resins, Plant; Visceral Pain	2019

Article

Year

Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome.

Minerva gastroenterology, 2023, Volume: 69, Issue:1

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders. IBS is characterized by recurrent chronic abdominal pain and altered bowel habits in the absence of organic damage. Although there are reviews and guidelines for treating IBS, the complexity and diversity of IBS presentation make treatment difficult. Treatment of IBS focuses on relieving symptoms as mild signs and symptoms can often be controlled by managing stress and by making changes in diet and lifestyle. The use of nutraceutical compounds has been advocated as a possible alternative treatment in patients with IBS. COLONIR. An initial cohort of 1004 consecutive patients referred to 25 different Units of Internal Medicine a/o Gastroenterology in Italy to perform colonoscopy for intestinal symptoms was asked to participate. Patients were treated for 2 months with three doses of nutraceuticals/day after meals namely COLONIR. After 2 months, 899 patients completed the follow-up. COLONIR. These promising results, here reported, need to be confirmed, valuating the efficacy of COLONIR

Topics: Abdominal Pain; Chamomile; Charcoal; Chronic Pain; Dietary Supplements; Flower Essences; Gastrointestinal Diseases; Glycyrrhiza; Humans; Irritable Bowel Syndrome; Mentha; Probiotics; Tryptophan

2023

Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin.

Nutrients, 2019, Dec-20, Volume: 12, Issue:1

Abdominal pain is a frequent symptom of irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBDs). Although the knowledge of these pathologies is progressing, new therapeutic strategies continue to be investigated. In the present study, the effect of a system of molecules of natural origin (a medical device according to EU Directive 93/42/EC, engineered starting from

Topics: Abdominal Pain; Aloe; Animals; Chamomile; Colitis; Disease Models, Animal; Flavonoids; Male; Plant Preparations; Rats; Rats, Sprague-Dawley; Resins, Plant; Visceral Pain

2019